Back to search

Article

GDF5 modulation of MuSC pool as a potential therapeutic benefit for DMD

2025-10-15

Abstract excerpt

Duchenne muscular dystrophy (DMD) is a fatal disease caused by dystrophin deficiency, leading to degeneration of the entire musculature. To improve muscle pathophysiology and gene therapy for DMD, we investigated the potential of growth differentiation factor 5 (GDF5) in the DMD mdx mouse model. We showed that the overexpression of GDF5 in the muscle improved its histology, reduced inflammation, modulated regenera...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1bd6e369-0a3e-5ba0-9ed3-06f0959d468d
DOI
10.1101/2025.10.14.682261
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
GDF5 modulation of MuSC pool as a potential therapeutic benefit for DMDDOI 10.1101/2025.10.14.682261
Select a neighboring publication to make it the new centre.